Triple-receptor pharmacology preclinical assay endpoints and pathway-specific readouts
PMCID: PMC11133479
CrossRef Circulating Estradiol as an Independent Risk Factor for Metabolic DysfunctionAssociated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort Hyo Jung Cho, Seong Hee Kang, Hye Yeon Chon, SungA Bae, Eunju Kim, Seong Kyun Na, Su Jin Kim, Dooyeon Kim, Hye Ri Ahn, Huigyeong Kim, Jae Youn Cheong, Soon Koo Baik, Young Kul Jung, Soon Sun Kim, Hyung Joon Yim Journal of Korean Medical Science .2026;[Epub] CrossRef LY6D promotes hepatic steatosis via the GRB2AMPKSREBP1 signaling axis Qiurong Zhao, Linxin Chen, Sha Xie, Juanjuan Meng, Wei Cui, Yao Wu, Ting Zeng, Huaming Mou, Xiaohe Luo International Journal of Obesity .2026
An earlier short-term randomized trial did not find significant changes in several oxidative-stress measures